Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Kimberly Blackwell, M.D., is the CEO of Zentalis Pharmaceuticals, Inc., a biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. Dr. Blackwells leadership is marked by her commitment to advancing oncology research, driving clinical development, and addressing unmet medical needs in cancer care. With extensive experience in oncology and drug development, she has played a key role in guiding Zentalis Pharmaceuticals through critical stages of research and clinical trials. Her strategic vision focuses on leveraging cutting-edge science to develop novel therapies and improve patient outcomes. Under her guidance, Zentalis Pharmaceuticals is making significant progress in the development of transformative cancer treatments, contributing to advancements in oncology and patient care.
